SITE014-0063

SITE014 (NLD) › SITE014-0063

SITE014-0063

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE014 (NLD) · Dr. Moreau
consented 2025-11-08

enrolled

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-01-30 (study day 253); relationship: NOT RELATED

moderate assessed

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-11-18 (study day 180); relationship: NOT RELATED

moderate assessed

Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-10-05 (study day 136); relationship: NOT RELATED

mild assessed

Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-07-15 (study day 54); relationship: NOT RELATED

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.